CopyFind
Mypred 40mg Injection
medicine 📍 IN

Mypred 40mg Injection

90,00 ₹

Analogs of Mypred 40mg Injection

Find cheaper analogs and generic equivalents for Mypred 40mg Injection.

Ingredients

Substancja czynna: Methylprednisolone


Przegląd produktu

About Mypred

Mypred is a medication containing the active ingredient Methylprednisolone, classified as Corticosteroid medication. Methylprednisolone, sold under the brand name Medrol among others, is a synthetic glucocorticoid, primarily prescribed for its anti-inflammatory and immunosuppressive effects. It is either used at low doses for chronic illnesses or used at high doses during acute flares.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1
  • Used for: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice
  • Used for: synthetic analogs may be used in conjunction with mineralocorticoids where applicable

Active Ingredient & Action

Methylprednisolone, the active ingredient in Mypred, belongs to the Corticosteroid medication class. INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy minera…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Mypred. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Mypred for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Mypred 40mg Injection.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.